semaglutide for kidney failure just got FDA-approved disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in VisualAbstract: Semaglutide Improves RACGP - Study links Ozempic

A simple clinical examination looking for asymmetry, irregular borders, color variation, diameter greater than 6 mm, and change over time or elevated lesion should be suspicious

Department of Justice/ Drug Enforcement Administration

That rules out both weight and glucose as the primary explanation

Within this mechanistic framework, natural compounds with antioxidant and anti-inflammatory properties, including vitamins C and E, glutathione precursors, CoQ10, L-carnosine, polyphenols including quercetin, resveratrol, and curcumin, and saffron metabolites like crocin and safranal show biological plausibility and preliminary efficacy on biochemical and behavioral endpoints